Chiesi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIESI, and what generic alternatives to CHIESI drugs are available?
CHIESI has fifteen approved drugs.
There are forty-eight US patents protecting CHIESI drugs.
There are three hundred and four patent family members on CHIESI drugs in forty-one countries and fifty-three supplementary protection certificates in eighteen countries.
Summary for Chiesi
| International Patents: | 304 |
| US Patents: | 48 |
| Tradenames: | 16 |
| Ingredients: | 10 |
| NDAs: | 15 |
| Patent Litigation for Chiesi: | See patent lawsuits for Chiesi |
Drugs and US Patents for Chiesi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-001 | Feb 21, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Chiesi | CLEVIPREX | clevidipine | EMULSION;INTRAVENOUS | 022156-001 | Aug 1, 2008 | RX | Yes | Yes | 10,010,537 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Chiesi | FILSUVEZ | birch triterpenes | GEL;TOPICAL | 215064-001 | Dec 18, 2023 | RX | Yes | Yes | 9,352,041 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | RX | Yes | Yes | 8,455,524 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | RX | Yes | No | 10,555,938 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chiesi | FERRIPROX | deferiprone | TABLET;ORAL | 212269-001 | May 19, 2020 | RX | Yes | Yes | 10,940,115 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chiesi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-001 | Dec 21, 2012 | 5,739,135 | ⤷ Try a Trial |
| Chiesi | CARDENE | nicardipine hydrochloride | INJECTABLE;INJECTION | 019734-001 | Jan 30, 1992 | 3,985,758 | ⤷ Try a Trial |
| Chiesi | FERRIPROX | deferiprone | SOLUTION;ORAL | 208030-002 | Apr 20, 2018 | 7,049,328 | ⤷ Try a Trial |
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-002 | Dec 21, 2012 | 5,712,279 | ⤷ Try a Trial |
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | 5,712,279 | ⤷ Try a Trial |
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | 6,492,365 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHIESI drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL | ➤ Subscribe | 2013-06-20 |
| ➤ Subscribe | Tablets | 500 mg | ➤ Subscribe | 2016-01-29 |
| ➤ Subscribe | Injection | 2.5 mg/mL, 10 mL Ampoules | ➤ Subscribe | 2006-12-27 |
| ➤ Subscribe | Inhalation Solution | 300 mg/4 mL | ➤ Subscribe | 2017-08-31 |
International Patents for Chiesi Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2007102084 | ⤷ Try a Trial |
| New Zealand | 572226 | ⤷ Try a Trial |
| Japan | 2014074069 | ⤷ Try a Trial |
| Poland | 2276541 | ⤷ Try a Trial |
| Eurasian Patent Organization | 022849 | ⤷ Try a Trial |
| Lithuania | C1725234 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chiesi Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0726894 | 12C0053 | France | ⤷ Try a Trial | PRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: NL 37621 20120725; FIRST REGISTRATION: GB - PL 16881/0003 20111123 |
| 1758555 | 353 5017-2016 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: BETULIN; REGISTRATION NO/DATE: EU/1/15/1069/001 20160118 |
| 0726894 | 1290008-0 | Sweden | ⤷ Try a Trial | PRODUCT NAME: CLEVIDIPINE; NAT. REG. NO/DATE: 42321 20120120; FIRST REG.: GB PL 16881/0003 20111123 |
| 1725234 | 2013/063 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/851/001-003 20130731 |
| 1758555 | 132016000072478 | Italy | ⤷ Try a Trial | PRODUCT NAME: ESTRATTO DI CORTECCIA DI BETULLA.(EPISALVAN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1069, 20160118 |
| 1725234 | SPC/GB14/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF OR THE PIPERIDINE N-OXIDE THEREOF; REGISTERED: UK EU/1/13/851/001 20130805; UK EU/1/13/851/002 20130805; UK EU/1/13/851/003 20130805 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
